Crossmark

Clinical characteristics and predictive models of HER2-low breast cancer patients who only received adjuvant chemotherapy: a real-world retrospective multicenter study

Crossref DOI link: https://doi.org/10.1038/s41698-025-00998-3

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Qinchuan

Wang, Yuying

Chen, Zikang

Chao, Yuqing

Chen, Lin

Li, Wenjing

Yang, Xia

Jiang, Zhinong

Li, Xiaoyan

Gao, Bo

Hu, Wenxian

Zhou, Jichun

Wang, Linbo

Li, Haitao

Zhang, Jun

Ding, Qiong

Lv, Xudong

Zhang, Hao

Zheng, Heming
Funding

Funding for this research was provided by:

Nature and Science Fund Public Program of Zhejiang Province (LGF22H160008)
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 9 March 2025

Accepted: 5 June 2025

First Online: 1 July 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below